Two-Photon Opportunity Leverage the May 2024 Nanoscribe partnership to position Advanced BioMatrix as the go-to supplier of bioresins and ECM materials for two-photon polymerization. Target 2PP labs and additive manufacturing groups using Quantum X; offer bundled resins with compatible ECM substrates and custom formulation services. Propose co-marketing and joint webinars to accelerate adoption.

ECM Portfolio Synergy Promote the ECM lineup (Laminin-511, Laminin-411, Laminin-221) alongside native matrix proteins to tissue engineering and 3D cell culture programs. Identify CROs and biotech startups in the region focused on organoids and disease models that require defined matrices; offer bundles, volume pricing, and technical support for assay development.

HyStem Expansion Highlight access to the HyStem hydrogel assets acquired in 2020 and position them for hydrogel-based cell culture and drug screening. Target CROs and pharma groups developing 3D culture models that benefit from HyStem-compatible formulations, with scalable manufacturing and custom mixing services.

Regional Growth Focus sales outreach on California and nearby states with mid-sized biotechs and academic labs active in tissue models and drug discovery. Emphasize local supply, rapid fulfillment, and regulatory compliance; propose pilot programs or starter bundles to reduce customer onboarding friction.

Tech-Driven Experience Showcase the company's modern cloud-based operations (AWS, iCloud) as a reliability and integration advantage. Offer easy procurement through digital channels, API-like ordering, and LIMS integration options to large customers; position as a scalable supplier for growing biotechs and contract manufacturers.